2 completed, 2 terminated, 1 withdrawn. 4 Phase 1, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 2, Terminated 2 |
| Phase 2 | 3 | Terminated 2, Withdrawn 1 |
Follow grapiprant: new trials by email Literature Review of grapiprant trials Research Report on grapiprant
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Grapiprant and Eribulin for the Treatment of Metastatic Inflammatory Breast Cancer Eribulin Mesylate, Grapiprant - Breast Inflammatory Carcinoma, Recurrent Breast Inflammatory Carcinoma | Phase 1 / Phase 2 | Terminated | M.D. Anderson Cancer Center | 6 | 2021-12-21 | 2025-06-13 |
| Grapiprant (ARY-007) and Pembrolizumab in Patients With Advanced or Metastatic Post-PD-1/L1 NSCLC Adenocarcinoma grapiprant and pembrolizumab - Non-small Cell Lung Cancer Adenocarcinoma | Phase 1 / Phase 2 | Terminated | Arrys Therapeutics | 18 | 2019-01-08 | 2021-02-21 |
| Grapiprant and Pembrolizumab in Patients With Advanced or Progressive MSS Colorectal Cancer grapiprant, grapiprant and pembrolizumab - Microsatellite Stable Colorectal Cancer | Phase 1 | Completed | Arrys Therapeutics | 54 | 2018-09-20 | 2023-10-24 |
| Phase II Trial of EP4 Receptor Antagonist, AAT-007 (RQ-07; CJ-023,423) in Advanced Solid Tumors RQ-00000007, Gemcitabine - Prostate Cancer, Non-Small Cell Lung Cancer | Phase 2 | Withdrawn | University of Maryland, Baltimore | 2017-06-01 | 2019-11-04 | |
| A Study Of The Effect Of CJ-023,423 On The Incidence Of Stomach Ulcers CJ-023,423, placebo, naproxen - Osteoarthritis | Phase 1 | Completed | Pfizer | 340 | 2006-11-01 | 2008-03-24 |
Breast Neoplasms (1) · Carcinoma, Non-Small-Cell Lung (1) · Disease Progression (1) · Inflammatory Breast Neoplasms (1) · Osteoarthritis (1) · Prostatic Neoplasms (1)
Arrys Therapeutics (2) · M.D. Anderson Cancer Center (1) · Pfizer (1) · University of Maryland, Baltimore (1)
United States (4)
Jason Sager, MD (1) · Martin Edelman, M.D., FACP (1) · Sadia Saleem (1) · Sergio Santillana, MD (1)